In a significant move that underscores the intersection of beauty and biotechnology, L’Oreal has announced its participation in a €35 million ($38.6 million) funding round for Abolis Biotechnologies. This investment, made in conjunction with specialty chemicals group Evonik, aims to cultivate bio-based ingredients that can transform the beauty product landscape. Abolis, a French start-up established […]